Inhibitors of the renin-angiotensin system, such as angiotensin-converting enzyme inhibitors and ARBs, prevented the generation of primary atrial fibrillation in patients with left ventricular hypertrophy and/or HF [22]. This evidence concerns the gene REN and left ventricular hypertrophy.